CD20-directed antibody-drug conjugates in non-hodgkin lymphoma: translating preclinical promise into clinical reality.

Saved in:
Bibliographic Details
Title: CD20-directed antibody-drug conjugates in non-hodgkin lymphoma: translating preclinical promise into clinical reality.
Authors: Omidvar L; Department of Internal Medicine, School of Medicine, Clinical Research Development Unit (CRDU), Valiasr Hospital, Birjand University of Medical Sciences, Birjand, Iran., Mer AH; Department of Food Quality Control, Shaqlawa Technical College, Erbil Polytechnic University, Erbil, Kurdistan Region, Iraq., Mirzaei Y; Department of Medical Biochemical Analysis, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq., Sanaye-Pasand MR; Student Research Committee, Pasteur Institute of Iran, Tehran, Iran., Jahandideh S; Department of Research and Development, Orchidgene co, Tehran, 1387837584, Iran., Hassani M; Department of Molecular Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. mahmoud.hassani@sbmu.ac.ir., Abdollahpour-Alitappeh M; Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran. m_abdollahpour@pasteur.ac.ir.
Source: Journal of hematology & oncology [J Hematol Oncol] 2026 May 13; Vol. 19 (1). Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-8722
DOI:10.1186/s13045-026-01807-5